ONCIMMUNE HOLDINGS PLC(ONC.UK)

21.00+0.000.00%

行情数据延迟15分钟

    • 最新
    • 推荐
      empty
      暂无内容
      • 公司概况

        公司名称
        ONCIMMUNE HOLDINGS PLC
        所属市场
        LSE
        成立日期
        - -
        员工人数
        - -
        办公地址
        - -
        邮政编码
        - -
        联系电话
        - -
        联系传真
        - -
        公司概况
        Oncimmune Holdings plc develops and commercializes products to diagnose cancer in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, a blood test for early detection of lung cancer. The company also develops EarlyCDT-Liver, a blood test for the early detection of hepatocellular carcinoma in high-risk patients with liver lesions of all sizes; SeroTag, a platform that is used to discover and validate biomarkers and develop precision diagnostic tools from minimally-invasive liquid biopsies; and NavigAID for autoimmune diseases. Oncimmune Holdings plc was incorporated in 2015 and is based in Nottingham, the United Kingdom.
        • 分时
        • 5日
        最高
        21.00
        今开
        21.00
        量比
        0.17
        最低
        21.00
        昨收
        21.00
        换手率
        0.00%
         
         
         
         

        热议股票